


Ask a doctor about a prescription for OMEPRAZOL AUROVITAS PHARMA 20 mg HARD GASTRO-RESISTANT CAPSULES
Package Leaflet: Information for the Patient
OmeprazoleAurovitas Pharma20 mg Hard Gastro-Resistant Capsules EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Follow the instructions for administration of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the Package Leaflet
This medicine contains the active substance omeprazole. It belongs to a group of medicines called "proton pump inhibitors". These medicines work by reducing the amount of acid produced by the stomach.
Omeprazole is indicated in adults for the short-term treatment of reflux symptoms (e.g., heartburn, acid regurgitation).
Reflux is the rise of acid from the stomach to the esophagus, which can become inflamed and painful. This can cause symptoms such as a painful burning sensation in the chest that rises to the throat (heartburn) and a sour taste in the mouth (acid regurgitation).
You may need to take the capsules for 2-3 consecutive days to achieve an improvement in symptoms.
You should consult a doctor if it worsens or does not improve after 14 days.
Do not take Omeprazole Aurovitas Pharma:
Do not take omeprazole if you are in any of the above cases. If you are not sure, talk to your doctor or pharmacist before taking omeprazole.
Warnings and precautions
Consult your doctor or pharmacist before starting to take omeprazole.
Do not take omeprazole for more than 14 days without consulting your doctor. If you do not experience relief, or if your symptoms worsen, consult your doctor.
This medicine may hide the symptoms of other diseases. Therefore, consult your doctor immediately if you experience any of the following conditions before starting to take omeprazole or during treatment:
If you suffer from a skin rash, especially in areas of the skin exposed to the sun, consult your doctor as soon as possible, as it may be necessary to interrupt treatment with omeprazole. Remember to mention any other symptoms you may notice, such as joint pain.
When taking omeprazole, kidney inflammation may occur. The signs and symptoms can include decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. You should report these signs to your doctor.
Patients should not take omeprazole as a preventive medication.
Taking Omeprazole Aurovitas Pharma with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or may take any other medicine, including those obtained without a prescription. Omeprazole may affect the mechanism of action of some medicines, and some medicines may affect omeprazole.
Do not take omeprazole if you are taking a medicine that contains nelfinavir(used to treat HIV infection).
You must specifically inform your doctor if you are taking clopidogrel(used to prevent blood clots).
Tell your doctor or pharmacist if you are taking any of the following medicines:
Taking Omeprazole Aurovitas Pharma with food and drinks
You can take your capsules with food or on an empty stomach. Do not chew or crush the capsules. Swallow the capsules whole with a glass of water.
Pregnancy and breastfeeding
Before taking omeprazole, inform your doctor if you are pregnant or trying to become pregnant. Your doctor will decide if you can take omeprazole during that time.
Your doctor will decide if you can take omeprazole if you are breastfeeding.
Driving and using machines
Omeprazole is unlikely to affect your ability to drive or use tools or machines.
Side effects such as dizziness and visual disturbances (see section 4) may occur. If they do, you should not drive or use machines.
Omeprazole Aurovitas Pharma contains Saccharose
This medicine contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
Omeprazole Aurovitas Pharma contains Sodium
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; it is essentially "sodium-free".
Follow the instructions for administration of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
The recommended dose is one 20 mg capsule once a day for 14 days. Contact your doctor if symptoms do not disappear after this time.
You may need to take the capsules for 2-3 consecutive days to achieve an improvement in symptoms.
How to take this medicine
What to do if you have problems swallowing the capsules
If you take more Omeprazole Aurovitas Pharma than you should
If you have taken more omeprazole than recommended, consult your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Omeprazole Aurovitas Pharma
If you forget to take a dose, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose. Do not take a double dose to make up for the missed doses.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you notice any of the following serious but rare side effects, stop taking omeprazole and consult your doctor immediately:
Other side effects are:
Common side effects(may affect up to 1 in 10 people)
Uncommon side effects(may affect up to 1 in 100 people)
Rare side effects(may affect up to 1 in 1,000 people)
Very rare side effects(may affect up to 1 in 10,000 people)
Side effects of unknown frequency(cannot be estimated from the available data)
In very rare cases, omeprazole may affect the white blood cells and cause immunodeficiency. If you have an infection with symptoms such as fever with a severely deteriorated general condition or fever with symptoms of local infection, such as neck, throat, or mouth pain, or difficulty urinating, you should consult your doctor as soon as possible to perform a blood test and rule out a lack of white blood cells (agranulocytosis). It is important that you provide information about the medicine you are taking at that time.
Do not worry about this list of possible side effects. You may not experience any of them. If you think any of the side effects you are experiencing is serious or if you notice any side effect not mentioned in this leaflet, tell your doctor or pharmacist.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not mentioned in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Omeprazole Aurovitas Pharma
Contents of the capsule: sugar spheres (sucrose and cornstarch), sodium lauryl sulfate, disodium phosphate, mannitol, hypromellose, macrogol 6000, talc, polysorbate 80, titanium dioxide, and 30% dispersion of methacrylic acid-ethyl acrylate copolymer (1:1).
Capsule shell: gelatin, quinoline yellow, and titanium dioxide.
Appearance of the product and contents of the pack
Omeprazole Aurovitas Pharma 20 mg hard gastro-resistant capsules are yellow opaque capsules containing white to off-white spherical microgranules.
Aluminum blister pack: 14 capsules.
HDPE bottles with silica gel desiccant in the polypropylene cap: 14 capsules.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Aurovitas Spain, S.A.U.
Avenida de Burgos, 16-D
28036 Madrid
Spain
Manufacturer:
Laboratorios Liconsa, S.A.
Avenida Miralcampo, 7, Polígono Industrial Miralcampo
19200 Azuqueca de Henares, Guadalajara
Spain
Date of the last revision of this leaflet:November 2023
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for OMEPRAZOL AUROVITAS PHARMA 20 mg HARD GASTRO-RESISTANT CAPSULES – subject to medical assessment and local rules.